Six notes:
1. Aurora Spine saw $4 million in first-quarter sales, a 35.7% increase from the same time in 2023.
2. The company saw a gross margin of 61.9%. That was a 10.2% increase year-over-year.
3. Sales of the SiLO-TFX sacroiliac joint implant and SiLo allograft implant made up 35.2% of quarterly sales.
4. The Zip 51 implant saw $544,190 in sales, an increase of 193% year-over-year.
5. Operating expenses in the first quarter were $2.75 million compared to $2.19 million in the first quarter of 2023.
6. Aurora Spine saw a net loss of $267,000 in the first quarter.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
